Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
204 studies found for:    "Mouth Neoplasms"
Show Display Options
Rank Status Study
21 Withdrawn ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
Conditions: Lip and Oral Cavity Cancer;   Head and Neck Cancer;   Oropharyngeal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: ONYX-015
22 Active, not recruiting Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Cancer;   Oral Cavity Cancer;   Oropharyngeal Cancer
Intervention: Drug: Valproic Acid
23 Terminated Excision Limits of Oral Cavity Tumor by Narrow Band Imaging
Condition: Cancer
Interventions: Device: Location of the suspected lesions;   Procedure: Biopsy;   Procedure: Lesion excision/Surgery
24 Active, not recruiting Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
Conditions: Mouth Neoplasms;   Head and Neck Neoplasms;   Tongue Neoplasms;   Carcinoma, Squamous Cell
Intervention: Drug: Sirolimus
25 Recruiting Oral Margin Spectroscopy Detection Using Optical Spectroscopy
Condition: Oral Tumors
Interventions: Device: FastEEM4 System;   Device: Multispectral Digital Microscope
26 Recruiting Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care
Conditions: Lip and Oral Cavity Squamous Cell Carcinoma;   Oral Cavity Verrucous Carcinoma;   Stage 0 Lip and Oral Cavity Cancer;   Tongue Cancer
Interventions: Procedure: fluorescence imaging;   Procedure: biopsy;   Procedure: examination;   Procedure: Comparison of surgical margins by COE vs. DVFE
27 Recruiting GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer
Conditions: Neoplasms, Oral;   Mouth Neoplasms
Intervention: Drug: GSK1120212
28 Completed The Feasibility Study of Dual-Section Nasogastric Tube
Conditions: Stroke;   Mouth Neoplasms
Intervention: Device: two-piece nasogastric tube
29 Recruiting Vitamin D - Celecoxib Therapy
Condition: Mouth Neoplasms
Interventions: Drug: celecoxib;   Drug: 1,25-dihydroxyvitamin D3 + celecoxib;   Drug: 1,25-dihydroxyvitamin D3
30 Not yet recruiting GDF15 Based TPF Induction Chemotherapy for OSCC Patients
Conditions: Mouth Neoplasms;   Carcinoma, Squamous Cell
Interventions: Drug: TPF induction chemotherapy;   Procedure: surgery group;   Radiation: Post-operative radiotherapy
31 Not yet recruiting a Trial of TPF(Docetaxel, Cisplatin and 5-fluorouracil ) Induction Chemotherapy in OSCC at cN2 Stage
Conditions: Mouth Neoplasms;   Carcinoma, Squamous Cell
Interventions: Drug: TPF induction chemotherapy;   Procedure: surgery;   Radiation: radiotherapy
32 Not yet recruiting Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage
Conditions: Mouth Neoplasms;   Carcinoma, Squamous Cell
Interventions: Drug: TPF group;   Procedure: surgery group;   Radiation: Post-operative radiotherapy
33 Terminated Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer
Conditions: Recurrent Squamous Cell Carcinoma of the Head and Neck;   Carcinoma, Squamous Cell;   Neoplasms, Squamous Cell;   Head and Neck Neoplasms;   Mouth Neoplasms;   Head and Neck Cancer
Intervention: Drug: Proxinium
34 Active, not recruiting F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
Conditions: Mouth Neoplasms;   Oropharyngeal Neoplasms;   Laryngeal Neoplasms;   Head and Neck Neoplasms
Intervention: Drug: F-18 Fluorothymidine
35 Recruiting Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Neoplasms;   Laryngeal Neoplasms;   Mouth Neoplasms;   Pharyngeal Neoplasms
Interventions: Drug: cetuximab (associated with radiotherapy);   Drug: cisplatin (associated to radiotherapy)
36 Terminated Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
Conditions: Advanced Squamous Cell Carcinoma of the Head and Neck;   Carcinoma, Squamous Cell;   Neoplasms, Squamous Cell;   Head and Neck Neoplasms;   Mouth Neoplasms;   Head and Neck Cancer
Intervention: Drug: Proxinium
37 Completed Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers
Conditions: Carcinoma, Squamous Cell;   Mouth Neoplasms;   Oropharyngeal Neoplasms;   Laryngeal Neoplasms;   Hypopharyngeal Neoplasms
Intervention:
38 Completed
Has Results
Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
Conditions: Lip and Oral Cavity Cancer;   Oral Leukoplakia;   Oropharyngeal Cancer;   Tongue Cancer
Interventions: Drug: Bowman-Birk inhibitor concentrate;   Other: placebo;   Other: laboratory biomarker analysis
39 Recruiting Polarized Reflectance Spectroscopy for Oral Lesions
Condition: Oral Cancer
Intervention: Device: Polarized Reflectance Spectroscopy System
40 Recruiting IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
Conditions: Oral Cancer;   Oropharynx Cancer;   Hypopharynx Cancer
Interventions: Procedure: IMRT 75 Gy;   Procedure: Conventional radiotherapy 70 Gy;   Drug: concomitant cisplatin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years